Back to search

Article

Tumor Diagnosis of FFPE Sample by Target Genome Sequencing From Multiple Sequencing Platforms

2022-03-11

Abstract excerpt

Technological innovation and increased affordability have contributed to the widespread adoption of target genome sequencing (TS) technologies in scientific research and clinical diagnostic applications. Cancer research consortia showed increasing acceptance of TS techniques to define the mutation landscape of multiple cancer types. These studies have primarily utilized Illumina’s sequencing instruments. In this s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4c4609c-6ccd-5601-81ff-b76e8f36b429
DOI
10.21203/rs.3.rs-1429288/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor Diagnosis of FFPE Sample by Target Genome Sequencing From Multiple Sequencing PlatformsDOI 10.21203/rs.3.rs-1429288/v1
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceSemantic proximity
TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted SequencingSemantic proximity
Comparison of next‑generation sequencing quality metrics and concordance in the detection of cancer‑specific molecular alterations between formalin‑fixed paraffin‑embedded and fresh‑frozen samples in comprehensive genomic profiling with the Illumina® TruSight Oncology 500 assaySemantic proximity
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologySemantic proximity
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.Semantic proximity
Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid TumorsSemantic proximity
Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity
Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panelSemantic proximity
A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumoursSemantic proximity
Concordance Study of a 520-Gene Next-Generation Sequencing-Based Genomic Profiling Assay of Tissue and Plasma Samples.Semantic proximity
Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application.Semantic proximity
Development and validation of an ultra-high sensitive next-generation sequencing assay for molecular diagnosis of clinical oncology.Semantic proximity
Select a neighboring publication to make it the new centre.